Ciprofloxacin vs levofloxacin for prophylaxis during hematopoietic stem‐cell transplantation
作者： Vanessa Copeland , Milena McLaughlin , Steven Trifilio
DOI: 10.1111/CTR.13145
关键词: Multiple myeloma 、 Surgery 、 Autologous hsct 、 Internal medicine 、 Levofloxacin 、 Medicine 、 Retrospective cohort study 、 Hematopoietic stem cell transplantation 、 Incidence (epidemiology) 、 Cohort study 、 Ciprofloxacin
摘要: The objective of the current retrospective study is to compare differences in rate breakthrough infections for ciprofloxacin versus levofloxacin prophylaxis an autologous HSCT patients treated multiple myeloma. This was a retrospective, cohort comparing hematopoietic stem-cell transplant (HSCT) recipients myeloma who received prophylaxis. A total 297 patients, 143 and 154 ciprofloxacin-treated were included. There significantly higher incidence bloodstream group (24/154) compared (10/143) p=0.03, primarily caused by statistically gram positive (ciprofloxacin (21/154) (8/143); p<0.01). Clinically relevant exist between fluoroquinolone agents used Levofloxacin more effective than reduce this study. This article protected copyright. All rights reserved.
sci-hub.se 参考文章(15)
E A Engels, J Lau, M Barza, Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. Journal of Clinical Oncology. ,vol. 16, pp. 1179- 1187 ,(1998) , 10.1200/JCO.1998.16.3.1179
J S Wolfson, D C Hooper, Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews. ,vol. 2, pp. 378- 424 ,(1989) , 10.1128/CMR.2.4.378
Michael A. Pfaller, Ronald N. Jones, Steven A. Marshall, Michael B. Edmond, Richard P. Wenzel, Nosocomial streptococcal blood stream infections in the SCOPE program: Species occurrence and antimicrobial resistance Diagnostic Microbiology and Infectious Disease. ,vol. 29, pp. 259- 263 ,(1997) , 10.1016/S0732-8893(97)00159-4
Marcie Tomblyn, Tom Chiller, Hermann Einsele, Ronald Gress, Kent Sepkowitz, Jan Storek, John R Wingard, JA Young, Michael J Boeckh, None, Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective Bone Marrow Transplantation. ,vol. 44, pp. 453- 455 ,(2009) , 10.1038/BMT.2009.254
S. Trifilio, J. Mehta, Antimicrobial prophylaxis in hematopoietic stem cell transplantation recipients: 10 years after. Transplant Infectious Disease. ,vol. 16, pp. 548- 555 ,(2014) , 10.1111/TID.12237
M. Cruciani, R. Rampazzo, M. Malena, L. Lazzarini, G. Todeschini, A. Messori, E. Concia, Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-Analysis Clinical Infectious Diseases. ,vol. 23, pp. 795- 805 ,(1996) , 10.1093/CLINIDS/23.4.795
Berjan A. Collin, Helen L. Leather, John R. Wingard, Reuben Ramphal, Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clinical Infectious Diseases. ,vol. 33, pp. 947- 953 ,(2001) , 10.1086/322604
Raymund R. Razonable, Mark R. Litzow, Yasmin Khaliq, Kerryl E. Piper, Mark S. Rouse, Robin Patel, Bacteremia Due to Viridans Group Streptococci with Diminished Susceptibility to Levofloxacin among Neutropenic Patients Receiving Levofloxacin Prophylaxis Clinical Infectious Diseases. ,vol. 34, pp. 1469- 1474 ,(2002) , 10.1086/340352
Giampaolo Bucaneve, Alessandra Micozzi, Francesco Menichetti, Pietro Martino, M Stella Dionisi, Giovanni Martinelli, Bernardino Allione, Domenico D'Antonio, Maurizio Buelli, A Maria Nosari, Daniela Cilloni, Eliana Zuffa, Renato Cantaffa, Giorgina Specchia, Sergio Amadori, Francesco Fabbiano, Giorgio Lambertenghi Deliliers, Francesco Lauria, Robin Foà, Albano Del Favero, None, Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. The New England Journal of Medicine. ,vol. 353, pp. 977- 987 ,(2005) , 10.1056/NEJMOA044097
Alison G Freifeld, Eric J Bow, Kent A Sepkowitz, Michael J Boeckh, James I Ito, Craig A Mullen, Issam I Raad, Kenneth V Rolston, Jo-Anne H Young, John R Wingard, None, Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Clinical Infectious Diseases. ,vol. 52, pp. 427- 431 ,(2011) , 10.1093/CID/CIR073